Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Outpatient Oncology Infusion Market Report 2026: Precision Oncology Driving the Market to Reach $20.21 Billion by 2030

globenewswire.com
BAX Baxter is mentioned for advancing infusion systems with its FDA-cleared Novum IQ pump, highlighting innovation and suitability for outpatient oncology centers, suggesting positive market impact. CAH Cardinal Health's acquisition of Integrated Oncology Network is noted as a strategic move to broaden its oncology network and enhance value-based care, indicating positive expansion and market strategy. MDT Medtronic plc is identified as a key player in the outpatient oncology infusion market, but no specific positive or negative actions are detailed in the article. BDX Becton Dickinson and Company is listed as a key player in the outpatient oncology infusion market, but the article does not provide specific details on its performance or recent activities.

Outpatient Oncology Infusion Market Report 2026: Precision Oncology Driving the Market to Reach $20.21 Billion by 2030 Dublin, April 01, 2026 (GLOBE NEWSWIRE) -- The "Outpatient Oncology Infusion Market Report 2026" has been added to ResearchAndMarkets.com's offering.

The outpatient oncology infusion market is experiencing significant growth, projected to increase from $14.02 billion in 2025 to $15.12 billion in 2026, at a CAGR of 7.8%. This growth is driven by rising cancer prevalence, enhanced outpatient oncology infrastructure, adoption of infusion therapies, improved survival rates requiring ongoing care, and availability of advanced infusion devices.

Looking ahead, the market is anticipated to reach $20.21 billion by 2030, maintaining a CAGR of 7.5%. Factors contributing to this upward trend include increased demand for precision oncology treatments, investments in outpatient infusion centers, expansion of home-compatible technologies, and emphasis on cost-efficient cancer care. Major trends include a shift toward outpatient treatment models, adoption of targeted therapies, use of smart infusion pumps, and expansion of ambulatory infusion centers.

The rise in cancer cases, largely attributed to aging populations, underscores the need for outpatient oncology infusion, allowing patients to receive chemotherapy, immunotherapy, or targeted therapy without hospital admission. For instance, Macmillan Cancer Support projects the number of individuals living with cancer in the UK to exceed 3 million, reaching 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040.

Innovation is at the forefront, with companies like Baxter International Inc. advancing infusion systems to enhance safety and treatment delivery. Baxter's U.S. FDA-cleared Novum IQ large-volume infusion pump exemplifies this, offering precise infusions with embedded safety features, suitable for outpatient oncology centers and hospitals alike. In another strategic move, Cardinal Health acquired Integrated Oncology Network in December 2024, aiming to broaden its oncology network and enhance value-based care delivery.

Leading companies, including Medtronic plc, Becton Dickinson and Company, and Fresenius Kabi AG, are key players in this market, with North America being the largest region in 2025. However, Asia-Pacific is anticipated to be the fastest-growing region during the forecast period.

Key Reasons to Purchase:

Market Segmentation and Competitive Landscape:

Company analysis covers leading firms such as Medtronic plc, Becton Dickinson, Baxter International, and others. It evaluates their market positioning, financials, and innovative capacities. The company scoring matrix ranks enterprises based on quantitative metrics such as market share, product innovation, and brand strength.

Geographic and Time Coverage

The report spans major regions including Asia-Pacific, Western and Eastern Europe, North America, and others. It also provides both historical data and a ten-year forecast, supported by industry-specific ratios and GDP correlations.

Key Attributes

The companies featured in this Outpatient Oncology Infusion market report include:

For more information about this report visit https://www.researchandmarkets.com/r/osracr

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment